TickerFacts.

A business in context

KNSA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001857177-26-000008

  2. 4 · Ownership change

    Report date 2026-09-01 · 0001835458-26-000012

  3. 4 · Ownership change

    Report date 2026-09-01 · 0001741533-26-000010

  4. 4 · Ownership change

    Report date 2026-09-01 · 0001532218-26-000016

  5. 4 · Ownership change

    Report date 2026-09-01 · 0001532218-26-000014

  6. 4 · Ownership change

    Report date 2026-07-15 · 0001464583-26-000008

  7. 4 · Ownership change

    Report date 2026-08-19 · 0001384243-26-000014

  8. 4 · Ownership change

    Report date 2026-08-01 · 0001454983-26-000008

  9. 8-K · Current report

    Report date 2026-07-28 · 0001730430-26-000031 · Items 2.02,9.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-087545

  11. 8-K · Current report

    Report date 2026-05-29 · 0001730430-26-000029 · Items 5.07

  12. 8-K · Current report

    Report date 2026-05-21 · 0001730430-26-000025 · Items 1.01,9.01

  13. 8-K · Current report

    Report date 2026-04-30 · 0001730430-26-000021 · Items 5.02

  14. 8-K · Current report

    Report date 2026-04-28 · 0001730430-26-000017 · Items 2.02,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-050359

  16. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001104659-26-044410

  17. 8-K · Current report

    Report date 2026-02-24 · 0001730430-26-000014 · Items 2.02,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-019168

  19. 8-K · Current report

    Report date 2026-01-10 · 0001730430-26-000010 · Items 5.02

  20. 8-K · Current report

    Report date 2026-01-12 · 0001730430-26-000005 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-103180

  22. 8-K · Current report

    Report date 2025-10-28 · 0001104659-25-102834 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-09-03 · 0001104659-25-086689 · Items 7.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-009738

  25. 8-K · Current report

    Report date 2025-07-29 · 0001104659-25-071413 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-06-05 · 0001104659-25-056665 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-06-03 · 0001104659-25-055990 · Items 5.07

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-005847

  29. 8-K · Current report

    Report date 2025-04-29 · 0001104659-25-040641 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-04-17 · 0001104659-25-038041 · Items 5.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-03 · 0001104659-25-036852

  32. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-001505

  33. 8-K · Current report

    Report date 2025-02-21 · 0001104659-25-016725 · Items 1.02,2.02,2.05,9.01

  34. 8-K · Current report

    Report date 2025-01-13 · 0001104659-25-002858 · Items 2.02,9.01

  35. SC 13G/A · Ownership disclosure

    0001104659-24-118928

  36. SC 13G/A · Ownership disclosure

    0000902664-24-006617

  37. SC 13G/A · Ownership disclosure

    0001104659-24-117745

  38. SC 13G · Ownership disclosure

    0002012383-24-004025

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-013840

  40. 8-K · Current report

    Report date 2024-10-29 · 0001104659-24-112034 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 15 transaction rows15SGrant / award: 37 transaction rows37AExercise / conversion: 66 transaction rows66MTax / exercise payment: 12 transaction rows12FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

132 matching transaction rows. Showing 101–132.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-01
2026-04-03
Ragosa MarkA · Grant / award
Acquired
Share Option
Derivative security
31150.00.0
2026-04-01
2026-04-03
Ragosa MarkM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
1846.00.0
2026-04-01
2026-04-03
Ragosa MarkA · Grant / award
Acquired
Performance Share Unit
Derivative security
15600.00.0
2026-04-01
2026-04-03
Ragosa MarkM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
1750.00.0
2026-04-01
2026-04-03
Ragosa MarkM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
1591.00.0
2026-04-01
2026-04-03
Paolini John F.F · Tax / exercise payment
Disposed
Class A Ordinary Share2821.048.13
2026-04-01
2026-04-03
Paolini John F.M · Exercise / conversion
Acquired
Class A Ordinary Share5831.0—
2026-04-01
2026-04-03
Paolini John F.A · Grant / award
Acquired
Restricted Share Unit
Derivative security
6700.00.0
2026-04-01
2026-04-03
Paolini John F.A · Grant / award
Acquired
Share Option
Derivative security
26750.00.0
2026-04-01
2026-04-03
Paolini John F.A · Grant / award
Acquired
Performance Share Unit
Derivative security
13400.00.0
2026-04-01
2026-04-03
Paolini John F.M · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
1624.00.0
2026-04-01
2026-04-03
Paolini John F.M · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
1750.00.0
2026-04-01
2026-04-03
Paolini John F.M · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
2457.00.0
2026-04-01
2026-04-03
Patel Sanj KM · Exercise / conversion
Acquired
Class A Ordinary Share21327.0—
2026-04-01
2026-04-03
Patel Sanj KF · Tax / exercise payment
Disposed
Class A Ordinary Share10313.048.13
2026-04-01
2026-04-03
Patel Sanj KM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
8609.00.0
2026-04-01
2026-04-03
Patel Sanj KM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
6237.00.0
2026-04-01
2026-04-03
Patel Sanj KA · Grant / award
Acquired
Performance Share Unit
Derivative security
60100.00.0
2026-04-01
2026-04-03
Patel Sanj KA · Grant / award
Acquired
Restricted Share Unit
Derivative security
30050.00.0
2026-04-01
2026-04-03
Patel Sanj KA · Grant / award
Acquired
Share Option
Derivative security
120150.00.0
2026-04-01
2026-04-03
Patel Sanj KM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
6481.00.0
2026-04-01
2026-04-03
Megna Michael RM · Exercise / conversion
Acquired
Class A Ordinary Share7564.0—
2026-04-01
2026-04-03
Megna Michael RF · Tax / exercise payment
Disposed
Class A Ordinary Share3205.048.13
2026-04-01
2026-04-03
Megna Michael RM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
2644.00.0
2026-04-01
2026-04-03
Megna Michael RA · Grant / award
Acquired
Share Option
Derivative security
14600.00.0
2026-04-01
2026-04-03
Megna Michael RM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
2362.00.0
2026-04-01
2026-04-03
Megna Michael RM · Exercise / conversion
Disposed
Restricted Share Unit
Derivative security
2558.00.0
2026-04-01
2026-04-03
Megna Michael RA · Grant / award
Acquired
Restricted Share Unit
Derivative security
3650.00.0
2026-04-01
2026-04-03
Megna Michael RA · Grant / award
Acquired
Performance Share Unit
Derivative security
7300.00.0
2026-01-15
2026-04-03
Tessari EbenA · Grant / award
Acquired
Class A Ordinary Share365.024.16
2026-01-15
2026-04-03
Moat RossA · Grant / award
Acquired
Class A Ordinary Share879.024.16
2026-01-15
2026-04-03
Megna Michael RA · Grant / award
Acquired
Class A Ordinary Share372.024.16

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001730430Kiniksa Pharmaceuticals International, plc

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Kiniksa Pharmaceuticals, Ltd. · former SEC name · 2018-02-27 to 2024-06-28

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$423.24M$450.52M
2023-12-31$270.26M$296.15M
2022-12-31$220.18M$251.18M
2021-12-31$38.54M$47.49M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗